State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
School of Biological Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Environ Microbiol Rep. 2018 Oct;10(5):583-593. doi: 10.1111/1758-2229.12682. Epub 2018 Sep 24.
Biofilm bacteria are embedded within a self-secreted extracellular matrix that contains a considerable amount of proteins including many extracellular enzymes. However, little is known about the roles of such enzymes in biofilm development. Here, we studied Pseudomonas aeruginosa aminopeptidase (PaAP, encoded by PA2939 that we named the gene as paaP in this study), a quorum-sensing-regulated enzyme and one of the most abundant extracellular proteins in the biofilm matrix of this opportunistic pathogen and environmental bacterium. We found that deletion of paaP in P. aeruginosa increased initial attachment and biofilm formation at early stages of biofilm development. After 24 h growth, loss of PaAP resulted in substantial cell death and biofilm disruption. Bacterial cell death was independent of biofilm matrix polysaccharide Psl, while biofilm disruption was due to the degradation of Psl matrix by dead-bacteria-released glycosyl hydrolase PslG, thereby leading to biofilm dispersion. PaAP functioned extracellularly and aminopeptidase catalytic activity was essential for its effect on biofilm development. Our data reveal an important role of extracellular aminopeptidase in biofilm development, suggesting PaAP as a therapeutic target for preventing P. aeruginosa infection and combating biofilm-related complications.
生物膜细菌被嵌入在自我分泌的细胞外基质中,该基质包含大量的蛋白质,包括许多细胞外酶。然而,对于这些酶在生物膜形成中的作用知之甚少。在这里,我们研究了铜绿假单胞菌氨肽酶(PaAP,由 PA2939 编码,我们在本研究中将该基因命名为 paaP),它是一种群体感应调节酶,也是这种机会性病原体和环境细菌生物膜基质中最丰富的细胞外蛋白之一。我们发现,在铜绿假单胞菌中缺失 paaP 会增加生物膜形成早期的初始附着和生物膜形成。在 24 小时生长后,PaAP 的缺失导致大量细胞死亡和生物膜破坏。细菌细胞死亡不依赖于生物膜基质多糖 Psl,而生物膜破坏是由于死菌释放的糖苷水解酶 PslG 降解 Psl 基质所致,从而导致生物膜分散。PaAP 在细胞外发挥作用,氨肽酶的催化活性对其生物膜发育的影响至关重要。我们的数据揭示了细胞外氨肽酶在生物膜形成中的重要作用,表明 PaAP 是预防铜绿假单胞菌感染和对抗生物膜相关并发症的治疗靶点。